Association between MICA polymorphisms, s-MICA levels, and pancreatic cancer risk in a population-based case-control study

Guillaume Onyeaghala, John Lane, Nathan Pankratz, Heather H. Nelson, Bharat Thyagarajan, Bruce Walcheck, Kristin E. Anderson, Anna E. Prizment

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Background Pancreatic tumor cells may avoid immune surveillance by releasing the transmembrane major histocompatibility complex class I chain-related A (MICA) protein in soluble form (s-MICA). We hypothesized that the presence of the A5.1 polymorphism in the MICA gene, which encodes a truncated MICA protein, is associated with higher s-MICA levels and increased pancreatic cancer risk. Methods MICA alleles and s-MICA levels were measured in 121 pancreatic cancer cases and 419 controls. General linear regression with a log transformation assessed geometric means of s-MICA levels across MICA alleles. Unconditional logistic regression was used to calculate the odds ratio (OR) and 95% confidence intervals (CI) for pancreatic cancer associated with MICA alleles. Results After multivariate adjustment, participants with at least one copy of the A5.1 allele versus no A5.1 allele had 1.35 (95% CI: 1.05–1.74) times greater s-MICA levels (1.65 times higher for cases and 1.28, for controls) and increased risk of pancreatic cancer (OR = 1.91, 95% CI: 1.05–3.48). Conclusions Our study suggests higher risk of pancreatic cancer among those with the MICA A5.1 polymorphism, which may be explained by an increase in s-MICA secretion and impaired immune response. Impact These findings provide further evidence at the genetic and molecular level of the important role of MICA in pancreatic cancer development, and may have important implications with regards to pancreatic cancer screening.

Original languageEnglish (US)
Article numbere0217868
JournalPloS one
Volume14
Issue number6
DOIs
StatePublished - Jun 2019

Bibliographical note

Funding Information:
Research was supported by Institutional Research Grant #124166-IRG-58-001-55-IRG21 from the American Cancer Society (https://www. cancer.org). A.E. Prizment was supported by the National Center for Advancing Translational Sciences of the NIH Award Number UL1 TR000114 (https://www.nih.gov/). B.W. R01CA203348 from the National Institutes of Health (https://www.nih. gov/). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Fingerprint Dive into the research topics of 'Association between MICA polymorphisms, s-MICA levels, and pancreatic cancer risk in a population-based case-control study'. Together they form a unique fingerprint.

Cite this